NCT00804206终止4 期
Phase 4 Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation
Asociación para Evitar la Ceguera en México1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Central macular thickness
研究概览
简要总结
Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with proliferative diabetic retinopathy
- •patients with macular edema
排除标准
- •patients with previous treatments
- •patients with ocular surgeries
研究组 & 干预措施
Group A
Experimental
Bevacizumab before panretinal photocoagulation.
干预措施: bevacizumab (Drug)
Group B
Experimental
Bevacizumab after panretinal photocoagulation
干预措施: bevacizumab (Drug)
结局指标
主要结局
Central macular thickness
时间窗: baseline, 10 days, 52 days, 85 days
次要结局
- Best corrected visual acuity(baseline, 10 days, 52 days, 85 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Effect of the Adjunctive IVB Before PRPDiabetic RetinopathyNCT01504724Kyungpook National University Hospital30
Unknown
2 期
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous HemorrhageVitreous Hemorrhage Secondary to PDRNCT01091896University of Sao Paulo1
Unknown
3 期
Bevacizumab Versus Ranibizumab in Age Related Macular DegenerationAge Related Macular DegenerationNCT01014468Instituto de Olhos de Goiania500
终止
2 期
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular DegenerationAge Related Macular DegenerationNCT00347399Asociación para Evitar la Ceguera en México25
Unknown
2 期
Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical TrialAge Related Macular DegenerationNCT03609307Shahid Beheshti University of Medical Sciences40